David Greenspan Slate Path Capital
David Greenspan is the founder of Slate Path Capital, a long/short equity firm with roots in the Tiger Management network. The firm conducts fundamental research across sectors with an emphasis on differentiated views rather than index hugging. Greenspan’s filings attract attention among investors who follow Tiger Cub-style managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$141M |
| 2 |
Snap
SNAP
|
+$116M |
| 3 |
IBM
IBM
|
+$101M |
| 4 |
Viatris
VTRS
|
+$98.5M |
| 5 |
Insulet
PODD
|
+$76.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
X
US Steel
X
|
+$170M |
| 2 |
Micron Technology
MU
|
+$112M |
| 3 |
EXE
Expand Energy Corp
EXE
|
+$98.7M |
| 4 |
KraneShares CSI China Internet ETF
KWEB
|
+$90.9M |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$78.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.92% |
| 2 | Healthcare | 22.32% |
| 3 | Materials | 13.96% |
| 4 | Energy | 10.91% |
| 5 | Industrials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
New York Times
NYT
$10.6B
| $73.9M | 1.64% |
1,508,000
| – | – |
|
27
TransDigm Group
TDG
$66.4B
| $71.4M | 1.59% |
70,600
-23,600
| -25% | -$21.8M |
|
28
Inspire Medical Systems
INSP
$1.8B
| $59.8M | 1.33% |
+294,000
| New | +$47.6M |
|
29
NOV
NOV
$7.28B
| $57.8M | 1.28% |
2,848,000
-2,218,000
| -44% | -$43.6M |
|
30
Organon & Co
OGN
$3.61B
| $51.6M | 1.15% |
+3,580,786
| New | +$48.7M |
|
31
Coinbase
COIN
$49.2B
| $40.9M | 0.91% |
235,300
-141,600
| -38% | -$15.5M |
|
32
Arrowhead Research
ARWR
$12.3B
| $40.7M | 0.9% |
+1,329,000
| New | +$35.3M |
|
33
Perrigo
PRGO
$1.98B
| $39.4M | 0.88% |
+1,225,711
| New | +$36.6M |
|
34
Alphatec Holdings
ATEC
$1.46B
| $32.6M | 0.72% |
+2,155,000
| New | +$25.8M |
|
35
PBF Energy
PBF
$8.72B
| $32.3M | 0.72% |
735,708
-167,292
| -19% | -$7.6M |
|
36
Valaris
VAL
$6.09B
| $31.9M | 0.71% |
465,000
| – | – |
|
37
Celestica
CLS
$37.4B
| $28.3M | 0.63% |
966,000
-416,000
| -30% | -$11.1M |
|
38
Roivant Sciences
ROIV
$26.2B
| $27.6M | 0.61% |
+2,460,000
| New | +$24M |
|
|
NARI
39
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $27.1M | 0.6% |
+418,000
| New | +$25.2M |
|
|
40
KraneShares CSI China Internet ETF
KWEB
$5.28B
| $24.4M | 0.54% |
903,337
-3,355,663
| -79% | -$90.9M |
|
41
Itaú Unibanco
ITUB
$82.4B
| $23.9M | 0.53% |
3,903,185
| – | – |
|
42
Banco Bradesco
BBD
$33.9B
| $20.4M | 0.45% |
5,824,000
| – | – |
|
|
FYBR
43
DELISTED
Frontier Communications
FYBR
| $16.8M | 0.37% |
661,502
+184,700
| +39% | +$3.73M |
|
44
Sibanye-Stillwater
SBSW
$8.9B
| $16.7M | 0.37% |
+3,079,000
| New | +$15.9M |
|
45
Invivyd
IVVD
$294M
| $14.7M | 0.33% |
3,735,000
| – | – |
|
46
Perimeter Solutions
PRM
$5.15B
| $13.9M | 0.31% |
3,024,000
-2,816,000
| -48% | -$10.8M |
|
47
Seadrill
SDRL
$2.96B
| $11.8M | 0.26% |
249,700
| – | – |
|
48
Century Aluminum
CENX
$4.35B
| $10.7M | 0.24% |
+878,000
| New | +$6.89M |
|
49
Banco Macro
BMA
$4.66B
| $9.53M | 0.21% |
+332,000
| New | +$7.57M |
|
50
Cue Biopharma
CUE
$174M
| $6.34M | 0.14% |
80,082
| – | – |
|
Similar funds
David Greenspan's Q4 2023 Portfolio in Review
As of Q4 2023, David Greenspan held 67 positions worth $4.51B, up 26% from $3.59B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
David Greenspan deployed $361M of net new capital in Q4 2023, opening 17 new positions and adding to 11 existing holdings. Its largest new stake was Hewlett Packard: 8,626,000 shares worth $146M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was US Steel, an estimated $170M trimmed.
- David Greenspan's largest Q4 2023 buy was Hewlett Packard: 8,626,000 shares worth $146M.
- David Greenspan added most to Viatris in Q4 2023, an estimated $98.5M increase.
- David Greenspan's biggest Q4 2023 reduction was US Steel, cutting an estimated $170M.
- David Greenspan fully exited Expand Energy Corp in Q4 2023, selling an estimated $98.7M.
- David Greenspan's ten largest holdings make up 46% of its $4.51B portfolio in Q4 2023.
- David Greenspan opened 17 new positions and closed 8 in Q4 2023.
- David Greenspan's portfolio value rose 26% quarter-over-quarter to $4.51B.
Based on Slate Path Capital's 13F filing for Q4 2023, filed 14 Feb 2024.